DAPAgliflozin for Renal Protection in Heart Transplant Recipients — StellaPhase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(6 sites)
Netherlands
University Medical Center Groningen, Groningen Erasmus Medical Center, Rotterdam Norway
Oslo University Hospital, Rikshospitalet, Oslo, Oslo County Sweden
Sahlgrenska University Hospital, Gothenburg Skane University Hospital, Lund Karolinska University Hospital, Stockholm Last updated October 2024